These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Reeth KV, Brown I, Essen S, Pensaert M. Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499 [Abstract] [Full Text] [Related]
24. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Wesley RD, Lager KM. Vet Microbiol; 2006 Nov 26; 118(1-2):67-75. PubMed ID: 16939702 [Abstract] [Full Text] [Related]
25. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Sui Z, Chen Q, Wu R, Zhang H, Zheng M, Wang H, Chen Z. Arch Virol; 2010 Apr 26; 155(4):535-44. PubMed ID: 20195654 [Abstract] [Full Text] [Related]
26. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs. Wen F, Yu H, Yang FR, Huang M, Yang S, Zhou YJ, Li ZJ, Tong GZ. Arch Virol; 2014 Nov 26; 159(11):2957-67. PubMed ID: 24957653 [Abstract] [Full Text] [Related]
28. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vincent AL, Lager KM, Ma W, Lekcharoensuk P, Gramer MR, Loiacono C, Richt JA. Vet Microbiol; 2006 Dec 20; 118(3-4):212-22. PubMed ID: 16962262 [Abstract] [Full Text] [Related]
34. Effect of inactivation method on the cross-protective immunity induced by whole 'killed' influenza A viruses and commercial vaccine preparations. Furuya Y, Regner M, Lobigs M, Koskinen A, Müllbacher A, Alsharifi M. J Gen Virol; 2010 Jun 15; 91(Pt 6):1450-60. PubMed ID: 20147516 [Abstract] [Full Text] [Related]
36. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice. Xie H, Liu TM, Lu X, Wu Z, Belser JA, Katz JM, Tumpey TM, Ye Z. J Infect Dis; 2009 Dec 15; 200(12):1874-83. PubMed ID: 19909080 [Abstract] [Full Text] [Related]
37. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant. Hasegawa H, Ichinohe T, Strong P, Watanabe I, Ito S, Tamura S, Takahashi H, Sawa H, Chiba J, Kurata T, Sata T. J Med Virol; 2005 Jan 15; 75(1):130-6. PubMed ID: 15543590 [Abstract] [Full Text] [Related]
38. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME, Roth JA. Vet Pathol; 2012 Nov 15; 49(6):900-12. PubMed ID: 22461226 [Abstract] [Full Text] [Related]